Advertisement

Antibiotics pp 166-168 | Cite as

Pluramycin

  • Nobuo Tanaka

Abstract

Pluramycin A, obtained from the culture broth of Streptomyces pluricolorescens by Maeda et al. (1956), is a basic antibiotic. It forms orange needle crystals which are yellow in acid and purple in alkali. The molecular formula, C20H25O5N, was suggested and confirmed by S. Nakamura (personal communications). Another antibiotic, designated pluramycin B, was isolated from the same culture filtrate in a crude form. Both pluramycins A and B inhibit growth of bacteria and tumor cells. Ogawara et al. (1966) observed that a macromolecular antitumor substance (molecular weight 30,000–60,000) is also produced by the same organism. It consists of a pluramycin-like prosthetic group and a glycoprotein, and is designated plurallin.

Keywords

Minimal Inhibitory Concentration Minimal Inhibitory Concen Shigella Dysenteriae Crude Form Ehrlich Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lein, J., B. Heinemann, and A. Gourevitch: Induction of lysogenic bacteria as a method of detecting potential antitumor agents. Nature 196, 783 (1962).PubMedCrossRefGoogle Scholar
  2. Maeda, K., T. Takeuchi, K. Nitta, K. Yagishita, R. Utahara, T. Osato, M. Ueda, S. Kondo, Y. Okami, and H. Umezawa: A new antitumor substance, pluramycin. Studies on antitumor substances produced by actinomycetes. XI. J. Antibiotics (Japan), Ser. A 9, 75 (1956).Google Scholar
  3. Matsumae, A., and T. Hata: Morphological changes of bacteria induced by chemotherapeutic agents. I. A classification of chemotherapeutic agents based on their activities to induce morphological changes of Escherichia coli strain B. J. Antibiotics (Japan), Ser. A 17, 164 (1964).Google Scholar
  4. Nishibori, A.: Antitumor effect of pluramycin A on experimental animal tumors. Studies on antitumor products of streptomyces. II. J. Antibiotics (Japan), Ser. A 10, 213 (1957).Google Scholar
  5. Ogawara, H., K. Maeda, K. Nitta, Y. Okami, T. Takeuchi, and H. Umezawa: An antibiotic, plurallin, consisting of a pluramycin-like prosthetic group and a glycoprotein. J. Antibiotics (Japan), Ser. A 19, 1 (1966).Google Scholar
  6. Takeuchi, T., K. Nitta, and H. Umezawa: Antitumor effect of pluramycin crude powder on Ehrlich carcinoma of mice. Studies on antitumor substances produced by microorganisms. X. J. Antibiotics (Japan), Ser. A 9, 22 (1956).Google Scholar
  7. Takeuchi, T., T. Hikiji, K. Nitta, and H. Umezawa: Effect of pluramycin A on Ehrlich carcinoma of mice. Studies on antitumor substances produced by actinomycetes. Xiii. J. Antibiotics (Japan), Ser. A 10, 143 (1957).Google Scholar
  8. Tanaka, N., K. Nagai, H. Yamaguchi, and H. Umezawa: Inhibition of Rna and Dna polymerase reactions by pluramycin A. Biochem. Biophys. Research Commun. 21, 328 (1965).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1967

Authors and Affiliations

  • Nobuo Tanaka

There are no affiliations available

Personalised recommendations